[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Jonathan Burth, Chief Operating Officer of Vita Coco Company, Inc. (COCO), reported a sale of 10,000 shares of common stock on 09/12/2025 at a weighted average price of $40.003 under a Rule 10b5-1 trading plan, leaving him with 76,127 shares beneficially owned following the transaction. The Form 4 also discloses multiple outstanding non-qualified stock options with exercise prices ranging from $10.178 to $33.36 and various vesting schedules and exercisability dates. The filing was signed by Alison Klein, Attorney-in-Fact, on 09/16/2025.

Positive

• Sale effected under a Rule 10b5-1 trading plan, indicating pre-arranged transaction terms disclosed in the filing
• Clear disclosure of option details including exercise prices, amounts, exercisability and vesting schedules
• Form signed by attorney-in-fact (Alison Klein) indicating formal execution of filing

Negative

• Insider sold 10,000 shares, reducing beneficial ownership to 76,127 shares
• Significant outstanding option pool (multiple grants totaling hundreds of thousands of underlying shares) that may lead to future dilution

Insights

Securities Analyst

TL;DR: Officer sold 10,000 shares under a 10b5-1 plan; substantial option holdings remain outstanding.

The reported disposition of 10,000 shares at a weighted average price of $40.003 was effected pursuant to a Rule 10b5-1 trading plan, which indicates the sale was pre-arranged rather than a discretionary trade. After the sale the reporting person beneficially owned 76,127 shares. The Form 4 discloses extensive option exposure: multiple non-qualified options totaling 448,092 underlying shares across various strikes and vesting schedules, some fully exercisable and others subject to future vesting. For investors, the filing documents insider liquidity activity while showing continuing potential equity dilution from outstanding options.

Corporate Governance Expert

TL;DR: Transaction appears procedural and documented; option grants show multi-year vesting common for executives.

The filing clearly identifies the reporting person as an officer (Chief Operating Officer) and discloses the use of a 10b5-1 plan for the sale, which is a standard compliance mechanism. The schedule of option grants includes fully vested, currently exercisable options and several grants with multi-year vesting schedules. The Form 4 is complete in describing vesting and exercisability for each grant and includes an attorney-in-fact signature, meeting typical disclosure and governance protocols for insider transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Burth Jonathan

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/12/2025		S(1)		10,000	D	$40.003(2)	76,127	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178							(3)	12/16/2029	Common Stock	48,825		48,825	D
Non-Qualified Stock Option (right to buy)	$10.178							(4)	02/10/2030	Common Stock	222,950		222,950	D
Non-Qualified Stock Option (right to buy)	$10.178							(5)	01/11/2031	Common Stock	34,125		34,125	D
Non-Qualified Stock Option (right to buy)	$15							(6)	10/21/2031	Common Stock	58,043		58,043	D
Non-Qualified Stock Option (right to buy)	$15.36							(7)	08/15/2032	Common Stock	42,980		42,980	D
Non-Qualified Stock Option (right to buy)	$16.91							(8)	03/10/2033	Common Stock	14,205		14,205	D
Non-Qualified Stock Option (right to buy)	$26.18							(9)	03/04/2034	Common Stock	8,746		8,746	D
Non-Qualified Stock Option (right to buy)	$33.36							(10)	03/04/2035	Common Stock	13,218		13,218	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.03, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The stock option is fully vested and currently exercisable.

4. The stock option is fully vested and currently exercisable.

5. The stock option is fully vested and currently exercisable.

6. The stock option vests in four equal annual installments beginning on November 27, 2022.

7. The stock option vests in three equal annual installments beginning on August 15, 2025.

8. The stock option vests in four equal annual installments beginning on March 10, 2024.

9. The stock option vests in four equal annual installments beginning on March 4, 2025.

10. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

	By: Alison Klein, Attorney-in-Fact For: Jonathan Burth	09/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Jonathan Burth (COCO) sell and when?

He sold 10,000 shares of Vita Coco common stock on 09/12/2025 at a weighted average price of $40.003.

Was the sale executed under a pre-arranged plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan.

How many shares does Jonathan Burth beneficially own after the reported sale?

The Form 4 reports 76,127 shares beneficially owned following the reported transaction.

What derivative holdings does the Form 4 disclose for the reporting person?

The filing lists multiple non-qualified stock options with exercise prices from $10.178 to $33.36 and underlying common stock amounts for each option grant.

Are any options fully exercisable now?

Yes. Several stock options in the filing are noted as fully vested and currently exercisable.